Ceretype Neuromedicine: Funding, Investors & Team (Oct 2026)
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
Ceretype Neuromedicine has raised $2.2M across 1 funding round on record, the most recent a Seed of $2.2M announced in Jan 2024.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Ceretype Neuromedicine Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Ceretype Neuromedicine Funding Rounds
Ceretype Neuromedicine Founders and Leadership Team
No contact details are on record for this team yet.
Ceretype Neuromedicine Funding Compared to Other Artificial Intelligence Startups
Ceretype Neuromedicine's latest round of $2.2M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ceretype Neuromedicine in Artificial Intelligence and Cambridge
Companies Similar to Ceretype Neuromedicine
Sirona Medical Inc. is addressing the needs of today’s radiology practices with a novel cloud-native platform…
Leading health plans, program providers, and over 100 communities across the U.S., rely on CredibleMind to…
RapidCanvas is an AI platform that combines the precision and automation of AI agents with the deep domain…
Labelbox is a collaborative data training platform that creates and manages labeled data for machine learning…
Clueso is an AI-driven support system for SaaS applications.
Dapta is a software-as-a-service company that provides a platform with minimal coding required to create APIs…
Factored was co-founded with renowned AI expert Andrew Ng (Stanford/AI Fund/Google Brain/Coursera) and…
Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor…
Lightsprint provides an AI-native product development platform that supports collaborative software…
Suki is a leading technology company that provides AI-powered voice solutions for healthcare. Its mission is…
Drylab is an AI-powered bioinformatics platform for biomedical data analysis, research workflows, and…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Ceretype Neuromedicine Funding FAQs
What does Ceretype Neuromedicine do?
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
How much funding has Ceretype Neuromedicine raised?
Ceretype Neuromedicine has raised $2.2M across 1 round on record. The most recent is a Seed of $2.2M announced in Jan 2024.
When did Ceretype Neuromedicine last raise funding?
Ceretype Neuromedicine's most recent funding round on record is a Seed of $2.2M, announced in Jan 2024.
Who founded Ceretype Neuromedicine?
FundedIQ lists Emily Stern (Founder) at Ceretype Neuromedicine.
Where is Ceretype Neuromedicine headquartered?
Ceretype Neuromedicine is based in Cambridge, Massachusetts, United States.
How many employees does Ceretype Neuromedicine have?
Ceretype Neuromedicine is in the 1-10 employee band.
How does Ceretype Neuromedicine's funding compare to other Artificial Intelligence startups?
Ceretype Neuromedicine's latest round of $2.2M is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,243 tracked companies over the last two years.
About FundedIQ's Ceretype Neuromedicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ceretype Neuromedicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.